Immune Peptides in Plain Language
Immune peptides are research compounds that interact with the immune system — the body's defense network of cells, signals, and organs. Unlike drugs that suppress or broadly stimulate immunity, the compounds in the OSYRIS Immune category modulate specific immune mechanisms: inflammatory signaling, T-cell maturation, and neuroimmune communication.
Anti-inflammatory (KPV) — A tripeptide that blocks NF-κB, the master switch for inflammatory gene activation. Stops excessive inflammation at the source.
Adaptive immunity (Thymosin Alpha 1) — Promotes T-cell maturation and enhances immune cell quality. The only compound in the OSYRIS catalog approved as a medication in 35+ countries.
Neuroimmune (VIP) — A neuropeptide that bridges the nervous and immune systems, with receptors on both neurons and immune cells.
Integrated (KLOW stack) — KPV + BPC-157 + TB500 + GHK-Cu for protocols studying inflammation control alongside tissue repair.
What's in the OSYRIS Immune Category
| Compound | Immune Level | Mechanism |
|---|---|---|
| KPV | Anti-inflammatory | NF-κB inhibition |
| Thymosin Alpha 1 | Adaptive immunity | T-cell maturation |
| VIP | Neuroimmune | VPAC receptor signaling |
| KLOW | Integrated | Anti-inflammation + repair |
Where to Go Next
Choose Your Next Step
Move from the beginner overview into the category guide, collection page, or broader peptide primer depending on how deep you want to go next.
Immune Category Guide
See how NF-κB inhibition, T-cell maturation, and neuroimmune signaling fit together in the immune category.
Immune Collection
Browse KPV, Thymosin Alpha 1, VIP, and integrated immune/recovery stacks with their COAs and citations.
What Are Research Peptides?
Start with the broad primer on what peptides are, how they are studied, and why RUO context matters.
Frequently Asked Questions
Questions About What Are Immune Peptides?
Not in the simple "boost" sense. They modulate specific immune mechanisms. Thymosin Alpha 1 enhances immune cell quality. KPV reduces excessive inflammation. VIP bridges neural and immune signaling.
Thymosin Alpha 1 — approved in 35+ countries with clinical trial data from multiple randomized controlled studies.
The master transcription factor controlling hundreds of inflammatory genes. KPV blocks it from activating.
The study of how the nervous and immune systems interact. VIP is a research tool for this field.
Not in the US. Thymosin Alpha 1 is approved in 35+ other countries. OSYRIS versions are research-grade for laboratory use.
KPV + BPC-157 + TB500 + GHK-Cu — combining anti-inflammatory and tissue repair compounds for integrated protocols.
Keep Following the Research Trail
Thymosin Alpha 1 — The Immune Peptide With Clinical Proof
Thymosin Alpha 1 immune peptide research. T-cell maturation, dendritic cells, viral immunity. Approved in 35+ countries. PubMed cited.
VIP — The Neuropeptide That Bridges Neural and Immune Biology
VIP research overview covering VPAC receptors, neuroimmune signaling, inflammation control, circadian biology, and neuroprotection.
What Are Research Peptides?
What are research peptides? A plain-language introduction covering peptide biology, how they're made, categories, quality, and regulatory context.